Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study-Reference-Cited by-同舟云学术

Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study

Published:2017-04-16 Issue:9 Volume:83 Page:2034-2044
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Gorricho Javier¹,Garjón Javier²,Alonso Alvaro³,Celaya María Concepción²,Saiz Luis Carlos²,Erviti Juan²,López Antonio²

Affiliation:

1. Planning, Evaluation and Management Service, General Directorate of Health; Government of Navarre; Calle Irunlarrea 3 (Pabellón Docencia del Hospital de Navarra) 31008 Pamplona Navarre Spain

2. Subdirectorate of Pharmacy; Navarre Regional Health Service; Plaza de la Paz s/n 31002 Pamplona Navarre Spain

3. Rollins School of Public Health; Emory University; 1518 Clifton Road, NE Atlanta GA 30322 USA

Funder

Spanish Ministry of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13288/fullpdf

Reference28 articles.

1. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands;Southan;Nucl Acids Res,2016

2. The Concise Guide to PHARMACOLOGY 2015/16: G protein coupled receptors;Alexander;Br J Pharmacol,2015

3. The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors;Alexander;Br J Pharmacol,2015

4. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015

5. BTS Guidelines for the management of community acquired pneumonia in adults: update 2009;Lim;Thorax,2009

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Sodium-Glucose Cotransporter-2 Inhibitors vs Dipeptidyl Peptidase-4 Inhibitors With Pneumonia, COVID-19, and Other Adverse Respiratory Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis;Canadian Journal of Diabetes;2024-08

2. Divergences in Antiviral Therapy for Diabetic Patients with COVID-19;Pharmacophore;2024

3. Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients;Scientific Reports;2023-10-27

4. COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?;Current Molecular Pharmacology;2023-06

5. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami;Inflammopharmacology;2023-04-20